Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

Results

49

0 new

Companys with strong funding and high growth potential

49 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

0RV2

BioArctic
SEK 170.01-3.2%-42.7%SEK 14.9bSEK 292.86PS49.8xE98.4%0%

0A8R

Seagen
US$228.954.6%81.1%US$43.2bUS$229.12PS18.8xE71.8%n/a

0A8K

ImmunoGen
US$31.246.4%658.3%US$8.4bUS$29.16PS29.1xE45.9%n/a

BIOABS

BioArctic
SEK 173.900%n/aSEK 14.9bSEK 299.56PS49.8xE98.4%0%

0QW0

argenx
€480.45-1.0%0.7%€28.8b€509.11PS19.4xE58.4%n/a

0HKF

Axsome Therapeutics
US$95.691.8%27.9%US$4.6bUS$125.04PS15.8xE68.9%n/a

ARGXB

argenx
€481.80-0.9%1.2%€28.8b€510.54PS19.4xE58.4%n/a

0HOJ

Blueprint Medicines
US$92.677.0%85.0%US$5.8bUS$128.73PS16xE67.4%n/a

0L49

SCYNEXIS
US$1.5818.2%-54.2%US$59.1mUS$6.75PS6.1xE49.4%n/a

0JDK

Iovance Biotherapeutics
US$10.14-2.5%106.6%US$3.1bUS$24.39PS94xE66.3%n/a

0IV3

Geron
US$4.815.7%118.8%US$2.8bUS$7.47PS2067.9xE68.0%n/a

0QZU

Vertex Pharmaceuticals
US$467.77-3.4%32.4%US$120.0bUS$512.94PS11.6xE46.4%n/a

0QNA

Basilea Pharmaceutica
CHF 46.955.2%11.7%CHF 570.3mCHF 72.21PS3.8xE36.4%0%

LLA

LungLife AI
UK£0.150%n/aUK£3.7mUK£2.14PS168.9xE101.0%n/a

ORXs

Orexo
SEK 30.950%n/aSEK 635.8mSEK 63.57PS1xE71.3%n/a

0OB3

Valneva
€2.60-7.2%-55.8%€410.9m€7.89PS2.6xE25.7%n/a

0H22

BioInvent International
SEK 45.509.0%168.6%SEK 3.0bSEK 90.60PS56.5xE102.7%n/a

XSPRAS

Xspray Pharma
SEK 71.200%n/aSEK 1.7bSEK 104.67PB2.6xE122.4%n/a

0M26

XOMA Royalty
US$29.129.0%n/aUS$329.9mUS$85.73PS21.7xE74.3%n/a

0RC6

Pharma Mar
€47.7813.4%50.1%€835.2m€51.84PS5.3xE55.2%1.4%

0GHZ

Xspray Pharma
SEK 77.700%67.8%SEK 1.7bSEK 120.39PB2.5xE122.4%n/a

0KF3

Palatin Technologies
US$1.40-4.8%-10.8%US$24.8mUS$12.58PS4.2xE84.6%n/a

FUM

Futura Medical
UK£0.36-2.2%-19.3%UK£108.4mUK£1.34PS12.9xE188.3%n/a

0M40

Zynerba Pharmaceuticals
US$1.314.0%65.7%US$65.6mUS$1.26PB2.3xE67.2%n/a
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.